HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.

AbstractPURPOSE:
Four members of the fibroblast growth factor receptor (FGFR) family transduce signals of a diverse group of FGF ligands. The FGFR2-IIIb isoform is abundantly present in the normal pituitary gland with contrasting down-regulation in neoplastic pituitary cells. cDNA profiling identified the cancer-testis antigen melanoma-associated antigen A3 (MAGE-A3) as a putative target negatively regulated by FGFR2.
EXPERIMENTAL DESIGN:
Comparisons were made between normal and neoplastic human and mouse pituitary cells. Gene expression was examined by reverse transcription-PCR, DNA methylation was determined by methylation-specific PCR and combined bisulfite restriction analysis, and histone modification marks were identified by chromatin immunoprecipitation.
RESULTS:
Normal human pituitary tissue that expresses FGFR2-IIIb does not express MAGE-A3; in contrast, pituitary tumors that are FGFR2 negative show abundant MAGE-A3 mRNA expression. MAGE-A3 expression correlates with the presence and extent of DNA promoter methylation; more frequent and higher-degree methylation is present in the normal gland compared with pituitary tumors. Conversely, pituitary tumors are hypomethylated, particularly in females where MAGE-A3 expression is nearly thrice higher than in males. Estradiol treatment induces MAGE-A3 through enhanced histone 3 acetylation and diminished methylation. The effects of estradiol are directly opposed by FGF7/FGFR2-IIIb. Down-regulation of MAGE-A3 results in p53 transcriptional induction, also through reciprocal histone acetylation and methylation modifications.
CONCLUSIONS:
These findings highlight MAGE-A3 as a target of FGFR2-IIIb and estrogen action and provide evidence for a common histone-modifying network in the control of the balance between opposing signals.
AuthorsXuegong Zhu, Sylvia L Asa, Shereen Ezzat
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 14 Issue 7 Pg. 1984-96 (Apr 01 2008) ISSN: 1078-0432 [Print] United States
PMID18381936 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Estrogens
  • Histones
  • MAGEA3 protein, human
  • Neoplasm Proteins
  • RNA, Messenger
  • Fibroblast Growth Factor 2
Topics
  • Animals
  • Antigens, Neoplasm (genetics, metabolism)
  • Blotting, Western
  • Cell Proliferation
  • DNA Methylation
  • Estrogens (metabolism)
  • Female
  • Fibroblast Growth Factor 2 (metabolism)
  • Gene Expression
  • Gene Expression Regulation, Neoplastic
  • Histones (genetics)
  • Humans
  • Immunohistochemistry
  • Immunoprecipitation
  • Male
  • Mice
  • Neoplasm Proteins (genetics, metabolism)
  • Oligonucleotide Array Sequence Analysis
  • Pituitary Neoplasms (genetics, metabolism)
  • RNA, Messenger (analysis)
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: